Medtronic to redeem seven series of outstanding notes in full

By Taylor Fox

New York, Sept. 29 – Medtronic plc plans to redeem all of Medtronic, Inc.’s outstanding $1.5 billion of 3.15% senior notes due 2022, $530.2 million 2.75% senior notes due 2023, $432.5 million 3.625% senior notes due 2024 and $810 million $2.7 billion 3.5% senior notes due 2025, all of Covidien International Finance SA’s outstanding $650 million 3.2% senior notes due 2022 and $309.5 million 2.95% senior notes due 2023 and all outstanding €1.5 billion of Medtronic Global Holdings SCA’s 0% senior notes due 2021, according to a press release.

The notes will be redeemed on Oct. 29 at make-whole redemption prices.

Medtronic is a medical technology and services company based in Dublin.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.